Economic evaluations of interventions to prevent healthcare-associated infections – literature review
Each year around 3.2 million patients are infected with healthcare-associated infections following exposure in healthcare facilities across the European Union and a total of 37 000 of them die as a direct consequence. Healthcare-associated infections are therefore of considerable concern to patients, healthcare professionals and policy-makers alike.
The aim of this review is to assist decision-makers by identifying and summarising existing economic evaluations and cost-effectiveness analyses associated with the control and/or prevention of healthcare-associated infections and to establish general assumptions which would be desirable for a common framework to enable future cost-effectiveness analyses in European hospital settings.
COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update
19 Oct 2020 - This document provides guidance on infection prevention and control (IPC) measures to healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) in order to prevent COVID-19 infection.
External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019
15 Oct 2020 - This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
Infection prevention and control and preparedness for COVID-19 in healthcare settings - fifth update
6 Oct 2020 - This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.